Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

RBL001/RBL002 Phase I Clinical Trial (MERIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01684241
Recruitment Status : Completed
First Posted : September 12, 2012
Last Update Posted : January 18, 2020
Information provided by (Responsible Party):
BioNTech SE ( BioNTech RNA Pharmaceuticals GmbH )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2015
Actual Study Completion Date : July 2015